Literature DB >> 1315586

Penicillium marneffei infection in patients infected with human immunodeficiency virus.

K Supparatpinyo1, S Chiewchanvit, P Hirunsri, C Uthammachai, K E Nelson, T Sirisanthana.   

Abstract

From June 1990 to August 1991, 21 patients infected with the human immunodeficiency virus (HIV) presented with systemic mycosis caused by Penicillium marneffei. Between August 1987 and August 1991, only five patients were observed who had P. marneffei infection but not HIV infection. The clinical presentation included fever, cough, and generalized papular skin lesions. For 11 of these 21 patients, the presumptive diagnosis of P. marneffei infection could be made by microscopic examination of Wright's-stained bone marrow aspirate and/or touch smears of skin specimens obtained by biopsy several days before the results of culture were available. Initial clinical response to treatment with either parenteral amphotericin B or oral itraconazole was favorable in most patients. Epidemiological and clinical evidence suggest that this systemic mycosis is caused by an important opportunistic pathogen and that it should be included in the differential diagnosis of AIDS, at least for countries in areas of endemicity, i.e., Southeast Asia and China.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1315586     DOI: 10.1093/clinids/14.4.871

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  38 in total

1.  In vitro antifungal-drug susceptibilities of mycelial and yeast forms of Penicillium marneffei isolates in Cambodia.

Authors:  Borann Sar; Sambo Boy; Chantary Keo; Chan Chhaya Ngeth; Narom Prak; Mich Vann; Didier Monchy; Jean Louis Sarthou
Journal:  J Clin Microbiol       Date:  2006-09-13       Impact factor: 5.948

2.  Fifteen cases of penicilliosis in Guangdong, China.

Authors:  Xi Liyan; Lu Changming; Zhou Xianyi; Wang Luxia; Xie Suisheng
Journal:  Mycopathologia       Date:  2004-08       Impact factor: 2.574

Review 3.  Cavitary pulmonary disease.

Authors:  L Beth Gadkowski; Jason E Stout
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

Review 4.  Penicillium marneffei infection and recent advances in the epidemiology and molecular biology aspects.

Authors:  Nongnuch Vanittanakom; Chester R Cooper; Matthew C Fisher; Thira Sirisanthana
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

5.  Penicillium marneffei: types and drug susceptibility.

Authors:  P Imwidthaya; K Thipsuvan; A Chaiprasert; S Danchaivijitra; R Sutthent; J Jearanaisilavong
Journal:  Mycopathologia       Date:  2001       Impact factor: 2.574

6.  Invasive mold infections in cancer patients: 5 years' experience with Aspergillus, Mucor, Fusarium and Acremonium infections.

Authors:  V Krcmery; E Kunova; Z Jesenska; J Trupl; S Spanik; J Mardiak; M Studena; E Kukuckova
Journal:  Support Care Cancer       Date:  1996-01       Impact factor: 3.603

7.  Diagnostic utility of bone marrow sampling in HIV positive patients.

Authors:  M G Brook; H Ayles; C Harrison; C Rowntree; R F Miller
Journal:  Genitourin Med       Date:  1997-04

Review 8.  Talaromycosis (Penicilliosis) Due to Talaromyces (Penicillium) marneffei: Insights into the Clinical Trends of a Major Fungal Disease 60 Years After the Discovery of the Pathogen.

Authors:  Cunwei Cao; Liyan Xi; Vishnu Chaturvedi
Journal:  Mycopathologia       Date:  2019-12       Impact factor: 2.574

9.  Analysis of polymorphic microsatellite markers for typing Penicillium marneffei isolates.

Authors:  Brent A Lasker; Yuping Ran
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

10.  Phylogeny and PCR identification of the human pathogenic fungus Penicillium marneffei.

Authors:  K F LoBuglio; J W Taylor
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.